The levels of circulating adropin were investigated in disorders with low-grade chronic inflammation, such as type 2 diabetes, atherosclerosis, coronary artery disease, arterial hypertension, obstructive sleep apnea, and in patients on hemodialysis [8,32,39,45,46,47,48]. This evidence concerns the gene ENHO and atherosclerosis.